Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ludwig Enterprises Inc
(OP:
LUDG
)
0.1428
-0.0072 (-4.80%)
Streaming Delayed Price
Updated: 3:43 PM EST, Nov 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Ludwig Enterprises Inc
< Previous
1
2
Next >
Ludwig Enterprises Begins PCR Validation Test Process
November 07, 2024
Via
ACCESSWIRE
Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM)
October 24, 2024
Via
ACCESSWIRE
CORRECTING AND REPLACING: Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology
September 24, 2024
Via
ACCESSWIRE
Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology
September 24, 2024
Via
ACCESSWIRE
Ludwig Announces Acquisition of Intellectual Property and Patent
September 17, 2024
Via
ACCESSWIRE
Ludwig Announces Substantial Corporate Initiatives
August 14, 2024
Via
ACCESSWIRE
Ludwig Enterprises, Inc. Announces Marvin S. Hausman, M.D. as Chief Executive Officer
September 19, 2023
Via
ACCESSWIRE
LUDG Files Genomic Patent AI Uncovers Differentially Expressed Genes
May 09, 2023
Via
ACCESSWIRE
Ludwig Enterprises, Inc. (OTC: LUDG) Prepares to Trade on the OTCQB Market
January 12, 2023
Via
ACCESSWIRE
Ludwig Enterprises Receives IRB Approval on Bladder Cancer Study
January 03, 2023
Via
ACCESSWIRE
Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer
July 09, 2024
Via
ACCESSWIRE
Ludwig Enterprises Inc (OTC:LUDG) Funds Incurable Brain Cancer Study
March 27, 2024
Via
ACCESSWIRE
Ludwig Enterprises mRNA Bladder Cancer Study to be Launched
January 31, 2024
Via
ACCESSWIRE
Exousia AI Ludwig Enterprises Subsidiary Launches Liposome Research Program
January 09, 2024
Via
ACCESSWIRE
Ludwig Enterprises Appoints Scott Silverman as CFO
November 16, 2023
Via
ACCESSWIRE
Ludwig Enterprises Releases Annual 2022 Shareholder Letter
December 21, 2022
Via
ACCESSWIRE
Ludwig Enterprises Acquires Cutting-Edge Dietary Supplement Formula
December 06, 2022
Via
ACCESSWIRE
Ludwig Enterprises Announces Effectiveness of Form S-1 Registration Application, Becomes an SEC Reporting Company
November 14, 2023
Via
ACCESSWIRE
Ludwig Enterprises to Launch New Nutraceutical in Hair Loss Market
May 03, 2023
Via
ACCESSWIRE
Ludwig Enterprises Announces Launch of New Nutraceutical and Strategic Marketing Plan
April 25, 2023
Via
ACCESSWIRE
Ludwig Enterprises Launches NuGenea, Groundbreaking Nutraceutical to Fight Inflammation
April 12, 2023
Via
ACCESSWIRE
Decoding mRNA for Early Disease Detection, Treatment & Prevention
March 29, 2023
Via
ACCESSWIRE
Ludwig Enterprises Announces Agreement with Summit Bancorp to Assist with Cross Listing on the Canadian Stock Exchange
March 23, 2023
Via
ACCESSWIRE
Ludwig Enterprises Announces Intention to List on the Canadian Stock Exchange
March 21, 2023
Via
ACCESSWIRE
Ludwig Enterprises Developing New Partnerships to Fuel Growth
March 16, 2023
Via
ACCESSWIRE
Ludwig Enterprise mRNA Program Generating Broad Clinical Interest
March 14, 2023
Via
ACCESSWIRE
Ludwig Enterprises Announces Brand Name for Groundbreaking Nutraceutical
March 09, 2023
Via
ACCESSWIRE
Ludwig Enterprises Develops Program to Support Ketamine Clinics
March 07, 2023
Via
ACCESSWIRE
New Scientific Evidence Suggests How Chronic Illnesses May Be Prevented
February 22, 2023
Via
ACCESSWIRE
Ludwig Enterprises Launches Growth Plan
February 14, 2023
Via
ACCESSWIRE
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.